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Abstract
Background: Diagnostic reviews often include the
sensitivity/specificity results of individual studies. A
problem occurs when these data are pooled because
the correlation between sensitivity and specificity is
generally strongly negative, causing overestimation
of the pooled results. The diagnostic odds ratio (DOR),
defined as the odds of true positives vs. that of false
positives, may avoid this problem. The aim of the
study was to review the advantages and limitations
of the DORs.
Methods: A systematic review of 44 previously pub-
lished diagnostic studies was used as an example.
Results: DORs can be readily implemented in diag-
nostic research. Advantages include: (1) they adjust
for the negative and curvilinear correlations between
sensitivities and specificities, (2) they take account of
the heterogeneity between studies with respect to the
different thresholds chosen by the investigators in the
original studies, and (3) it is easy to extend the model
with covariates representing between-study differenc-
es in design. Limitations include: 1) the outcome
parameter is a summary estimate of both sensitivity
and specificity, and 2) the magnitude of the studies
included is not taken into account.
Conclusions: Reported sensitivities and specificities of
different studies assessing similar diagnostic tests are
not only negatively correlated, but also negatively
correlated in a curvilinear manner. It is appropriate to
take this negative curvilinear correlation into account
in the data pooling of such meta-analyses. The DORs
can be applied for that purpose.
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Introduction
In the past few years many novel diagnostic methods
have been developed, including multi-slice computer
tomography, magnetic resonance, positive emission
tomography and many others. Studies evaluating
their respective sensitivities and specificities have
been published, and meta-analyses of these studies
can be performed to establish whether the findings
are consistent and can be generalized across popu-
lations and variations in morbidity/treatment. Sensi-
tivity and specificity are estimators of accuracy of
diagnostic methods, as explained in the following
diagram.
Gold standard test Positive Negative
Diagnostic test Positive TP FP
Negative FN TN
TP, number of true positive; FP, false positive;
FN, false negative; and TN, true negative patients in
a study.
Sensitivitystrue positive rate (TPR)sTP/(TPqFN)
Specificitystrue negative rate (TNR)sTN/(TNqFP).
1-Specificitys(TNqFP)/(TNqFP)–TN/(TNqFP)
sFP/(TNqFP)sFPR
An intuitive approach to meta-analysis of diagnostic
studies is to pool the odds of sensitivity (sTPR/
(1–TPR) and specificity (sTNR/(1–TNR) of the sepa-
rate studies. Sensitivities and specificities are, how-
ever, dependent on one another. In addition, they are
dependent in a non-linear manner as shown in the
summary receiver operated characteristic (ROC)
curve in Figure 1. In order to account for these pro-
blems Moses and Wittemberg proposed diagnostic
odds ratios (DORs) of the sensitivities vs. specificities
(1). In recent years, this approach has been increas-
ingly used (2–6). The current paper uses the results
of a previously published review of diagnostic studies
(7) as an example, and reviews the advantages and
disadvantages of this novel method and discusses
alternative possibilities.
Diagnostic odds ratios
The accuracy of a diagnostic test is usually summa-
rized by two statistics: TPR or sensitivity, and the TNR
or specificity. They are often used to draw ROC curves
(Figure 1). Instead of the dual approach of sensitivity
and specificity, accuracy can also be summarized by
the DOR:
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Figure 1 Example of a summary receiver-operated-charac-
teristic (ROC) curve.
The proportion of true positive patients (ssensitivity) is
drawn against the proportion of false positive patients
(s1–specificity) using the results of multiple studies. With
many diagnostic tests, test results do not necessarily fall into
one of two categories, but rather into categories with vari-
able confidence in the presence of a disease.
Table 1 Example of meta-analysis of 17 diagnostic studies
of lymphangiography for assessment of lymph node
metastases.
Study no. TP FP FN TN
1 0 1 6 17
2 12 3 3 7
3 4 1 2 13
4 10 4 3 25
5 3 1 4 12
6 9 3 3 29
7 20 4 8 31
8 17 5 7 21
9 2 0 9 32
10 3 1 9 38
11 1 1 2 18
12 5 2 2 61
13 21 8 40 184
14 4 3 9 42
15 0 0 5 15
16 7 11 22 158
17 3 3 2 29
TP, true positive; FP, false positive; FN, false negative; TN,
true negative.
Table 2 Example of meta-analysis of 17 diagnostic studies
of computerized tomography (CT) imaging of lymph nodes
metastases.
Study no. TP FP FN TN
1 19 1 10 81
2 8 9 2 13
3 41 1 12 49
4 5 1 2 18
5 45 58 32 165
6 8 6 2 32
7 5 8 1 7
8 15 17 11 52
9 16 11 8 24
10 4 8 2 25
11 4 12 10 70
12 10 4 4 55
13 2 5 6 23
14 7 10 7 30
15 4 50 12 135
16 8 3 1 37
17 4 3 0 14
TP, true positive; FP, false positive; FN, false negative; TN,
true negative.
Table 3 Example of meta-analysis of 10 diagnostic studies
of magnetic resonance imaging (MRI) of lymph node
metastases.
Study no. TP FP FN TN
1 9 2 2 41
2 3 6 5 32
3 3 2 1 16
4 3 1 12 44
5 0 0 5 15
6 7 2 22 167
7 12 4 4 29
8 23 5 14 230
9 8 5 5 53
10 16 2 2 22
TP, true positive; FP, false positive; FN, false negative; TN,
true negative.
sensitivity/(1–sensitivity)
DORs
(1–specificity)/specificity
The DOR is an interesting term. It compares the
odds of true positive patients with that of false posi-
tives, and, thus summarizes the overall accuracy of a
diagnostic test. A problem is that, like any odds ratio,
it does not follow a Gaussian distribution and loga-
rithmic transformation is required. Linear regression
of the ln(DOR) on the statistic S is often applied for
analysis.
B E B ETPR FPR
C F C Fln(DOR)sln –ln and
D G D G1–TPR 1–FPR
B E B ETPR FPR
C F C FSsln qln
D G D G1–TPR 1–FPR
where TPR and FPR are the true and false positive
rates, and ln refers to the natural logarithm. Linear
regression analysis is simply fitting a straight line:
ln(DOR)saqb.S. ln(DOR) is the dependent and S the
independent variable. Although this is not obvious
from the model as given, this method is often suc-
cessful in producing a rather close linear fit to the
data. The a-value is the intercept and the b-value is
the regression coefficient. If sensitivity equals speci-
ficity, then TPRsTNRs1–FPR, and S reduces to 0.
Thus, the magnitude of the ln(DOR) at that point
equals the a-value. The DOR can be calculated by
back-log-transformation of the calculated intercept.
As an example, results from a previously published
review of 44 diagnostic studies (7) of imaging tech-
niques for lymph node metastases are used (Tables
1–3). The ln(DOR) and S-values calculated from the
lymphangiography-studies are entered into the SPSS
software program. We command statistics; regres-
sion; linear. The program produces an a-value of 2.09
wstandard error (SE)s0.35x. The DOR at the point
where Ss0 is then found by taking the invert of the
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Table 4 Intercepts (a-value) and slopes (b-value) of the linear regression lines of the DORs of the three diagnostic modalities
from Tables 1 through 3.
Diagnostic modality Intercept (SE) Regression (SE) DOR at Ss0 (SE) (p-value)
(a-value) coefficient (b-value)
Lymphangiography 2.09 (0.30) –0.35 (0.20) 8.08 (1.35) (-0.001 vs. CT and MRI)
CT 2.84 (0.44) 0.23 (0.14) 17.16 (1.55) (-0.001 vs. MRI and lymphangiography)
MRI 3.51 (0.56) 0.25 (0.17) 33.45 (1.75) (-0.001 vs. CT and lymphangiography)
DOR, diagnostic odds ratio; SE, standard error; CT, computed tomography; MRI, magnetic resonance imaging.
Figure 2 Summary ROC curves for the three diagnostic
modalities.
A diagonal line drawn from the top of the y-axis to the right
end of the x-axis contains the points of summary ROC curves
where sensitivity equals specificity, and thus Ss0. Along this
diagonal line, the distance of the MRI curve to the top of the
y-axis is shorter than that of the other curves, indicating a
better accuracy of this diagnostic method. This is supported
by a significantly larger DOR at p-0.001 (Table 4).
natural logarithm of 2.09s8.08 (SEs1.35). A sum-
mary of the results of the regression analyses are
shown in Table 4. The magnitude of DORs at Ss0 can
be used to estimate the degree of overall accuracy of
the diagnostic method. Table 4 shows that magnetic
resonance imaging (MRI) is significantly more accu-
rate than the other two methods of cardiac imaging
with p-0.001.
Constructing summary ROC curves
The results of the separate studies are used to cal-
culate the best fit a and b for the data. Subsequently,
the equation shown below is adequate to construct
the best-fit summary ROC curve from the a- and b-
values:
(1 b)(1–b) –1qw zB E1–FPR–a(1–b) C Fx |TPRs 1qe
D Gy FPR ~
The equation is entered into Maple 9.5 software
program for making graphs and we indicate the a-
and b-value. The software program produces the best
fit ROC curves for the three diagnostic methods (Fig-
ure 2). The curve closest to the top of the y-axis pro-
vides the best overall accuracy. A diagonal line from
the top of the y-axis to the right end of the x-axis con-
tains all the points on the summary ROC curves
where sensitivity equals specificity, and thus Ss0.
Along this diagonal line, the distance from the MRI
curve would be shorter than that of the other curves,
indicating better accuracy of this diagnostic method.
This is supported by a significantly larger DOR at
p-0.001 as shown in Table 4, and discussed in the
section above. The distances from the top of the y-
axis to the MR/CT/lymphangiography summary ROC
curves can be calculated using Pythagoras’ equation
for rectangular triangles, where
6 w(1–sensitivity)2q(1–specificity)2x, and equals:
for the MR curve 6 (0.182q0.182)s0.25,
for the CT curve 6 (0.222q0.222)s0.31,
for the lymphangiography curve 6 (0.262q0.262)s0.37.
Results and discussion
This paper shows that DORs can be readily imple-
mented in the meta-analyses of diagnostic studies. An
advantage of the DOR approach is that it incorporates
the special correlation between sensitivities and spec-
ificities of the included studies. Another advantage is
that it takes into account the heterogeneity between
studies with respect to the different thresholds chosen
by the investigators in the original studies. For partic-
ular reasons, some investigators prefer high sensitiv-
ity and accept low specificity, while others prefer the
reverse. These differences produce heterogeneity in
the DOR between studies, but this is taken into con-
sideration by regression of ln(DOR) on S. A subse-
quent advantage is that it is easy to extend the model
with covariates representing differences in design
between studies. However, this advantage is limited
because in the summary ROC model, these covariates
are supposed to affect sensitivity and specificity in a
similar manner, which is not always the case.
We need to mention some limitations. First, since
the outcome parameter is a summary estimate of
both sensitivity and specificity, no summary esti-
mates of sensitivity or specificity are available. Sec-
ond, the magnitude of the studies included in the
meta-analyses is not taken into account in the sum-
mary ROC method. Thus, it is impossible to weigh the
true positives and false positives of the studies sep-
arately (8). However, it is common to report sensitivity
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and specificity from diagnostic studies without account-
ing for the size of the sample from which they were
calculated (9).
Other commonly used test indicators for diagnostic
tests include positive predictive values, likelihood
ratios and Youden’s index. They are, in theory, useful
for diagnostic meta-analyses, particularly from a
bayesian perspective. However, they are rarely used
because they are not practical from a statistical view-
point due to numerical and ceiling problems (10).
As an alternative, multivariate methods for pooling
the meta-data accounting sensitivities and specifici-
ties can be used. For example, multivariate methods
such as multivariate analysis of variance (MANOVA)
with sensitivity and specificity as outcome variables
and different diagnostic modalities as predictor vari-
able can produce results similar to those of the DOR
method. In addition, it produces sensitivities and
specificities separately and adjusted for their interac-
tion (8). Again, a limitation with this approach is that
the magnitude of the separate studies is not account-
ed for, and the numbers of studies included in the
meta-analyses is often too small for reliable testing.
A rule of thumb, at least 10 studies per variable are
required for multivariate analyses.
We should add that, similar to therapeutic meta-
analyses, it is appropriate to apply scientific rules in
any meta-analysis of diagnostic studies including a
thorough search of the literature, strict inclusion cri-
teria and an assessment of the usual pitfalls of meta-
analyses such as publication bias, clinical hetero-
geneity, and lack of robustness (11).
Conclusions
Reported sensitivities and specificities of various
studies that assess similar diagnostic tests are not
only negatively correlated, but also correlated in a
curvilinear manner. It is appropriate to take this neg-
ative curvilinear correlation into account in the pool-
ing of data for meta-analyses. DORs can be applied
for this purpose.
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